Herwig Pongratz

Title: Herwig Pongratz: Innovator in Pharmaceutical Chemistry

Introduction

Herwig Pongratz is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of targeted therapies for various diseases. With a total of five patents to his name, Pongratz has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Pongratz's latest patents include groundbreaking work on FLT3 inhibitors. His invention focuses on small molecule compounds that serve as FLT3 inhibitors for the treatment of acute myeloid leukemia (AML). This patent outlines methods for synthesizing these compounds and their application in medical treatments. Another significant patent involves HDAC6 inhibitors, which feature improved solubility. This invention relates to small molecule compounds that act as HDAC inhibitors, with applications in cancer treatment. The patent also discusses methods for enhancing solubility by introducing basic substituents, allowing for the creation of pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Herwig Pongratz has worked with esteemed institutions such as Universität Regensburg and Zentaris AG. His work in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Pongratz has collaborated with notable colleagues, including Siavosh Mahboobi and Sabine Kuhr. These partnerships have further enriched his research endeavors and have led to advancements in the field.

Conclusion

Herwig Pongratz is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of serious diseases. His innovative patents and collaborations highlight his dedication to advancing medical science.